A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00287469

Recruitment Status : Withdrawn (IND was inactivated)

First Posted : February 6, 2006

Last Update Posted : December 28, 2016

Sponsor:

Collaborators:

GlaxoSmithKline

National Institute of Allergy and Infectious Diseases (NIAID)

Information provided by:

U.S. Army Medical Research and Materiel Command

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Withdrawn
Primary Completion Date :	No date given
Study Completion Date :	January 2004

Publications:

Worm HC, Schlauder GG, Brandstätter G. Hepatitis E and its emergence in non-endemic areas. Wien Klin Wochenschr. 2002 Aug 30;114(15-16):663-70. Review.

Worm HC, van der Poel WH, Brandstätter G. Hepatitis E: an overview. Microbes Infect. 2002 May;4(6):657-66. Review.

Emerson SU, Purcell RH. Running like water--the omnipresence of hepatitis E. N Engl J Med. 2004 Dec 2;351(23):2367-8.

Purcell RH. Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2401-6. Review. Erratum in: Proc Natl Acad Sci U S A 1994 Sep 13;91(19):9195.

Worm HC, Wirnsberger G. Hepatitis E vaccines: progress and prospects. Drugs. 2004;64(14):1517-31. Review.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007 Mar 1;356(9):895-903.

To Top